Gary W. Small
#129,447
Most Influential Person Now
Gary W. Small's AcademicInfluence.com Rankings
Gary W. Smallphilosophy Degrees
Philosophy
#6230
World Rank
#9232
Historical Rank
Logic
#3413
World Rank
#4566
Historical Rank
Download Badge
Philosophy Biology
Gary W. Small's Degrees
- Masters Medicine University of Southern California
- PhD Physiology University of Southern California
Why Is Gary W. Small Influential?
(Suggest an Edit or Addition)Gary W. Small's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. (1993) (8659)
- Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease (1994) (1772)
- Patterns of brain activation in people at risk for Alzheimer's disease. (2000) (1229)
- Practice parameter: Diagnosis of dementia (an evidence-based review) (2001) (1178)
- Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. (1997) (924)
- Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. (2001) (863)
- Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. (2002) (748)
- Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. (2000) (734)
- PET of brain amyloid and tau in mild cognitive impairment. (2006) (671)
- Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. (1995) (608)
- Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. (2003) (538)
- Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. (1997) (377)
- Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease (2001) (375)
- iBrain: Surviving the Technological Alteration of the Modern Mind (2008) (358)
- Age at onset in two common neurodegenerative diseases is genetically controlled. (2002) (332)
- Clinical Pharmacokinetics and Pharmacodynamics of Cholinesterase Inhibitors (2002) (332)
- Appendix B: Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology (2007) (314)
- Complete genomic screen in Parkinson disease: evidence for multiple genes. (2001) (302)
- Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. (1997) (298)
- Analysis of European mitochondrial haplogroups with Alzheimer disease risk (2004) (283)
- Cortical variability and asymmetry in normal aging and Alzheimer's disease. (1998) (280)
- Your brain on Google: patterns of cerebral activation during internet searching. (2009) (242)
- Serotonin 1A receptors in the living brain of Alzheimer's disease patients. (2006) (227)
- Life extension factor klotho enhances cognition. (2014) (225)
- Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. (2003) (224)
- PET scanning of brain tau in retired national football league players: preliminary findings. (2013) (220)
- Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers (2008) (213)
- National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. (2001) (212)
- Parkin mutations and susceptibility alleles in late‐onset Parkinson's disease (2003) (212)
- Identification of Novel Genes in Late-Onset Alzheimer's Disease (2000) (203)
- Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. (2001) (190)
- Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease (1995) (188)
- In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging (2015) (181)
- Neuroimaging Findings in Twins Discordant for Alzheimer’s Disease (1998) (173)
- Brain network local interconnectivity loss in aging APOE-4 allele carriers (2011) (171)
- Five days at outdoor education camp without screens improves preteen skills with nonverbal emotion cues (2014) (166)
- Effects of a 14-day healthy longevity lifestyle program on cognition and brain function. (2006) (165)
- Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial. (2017) (161)
- Current and future uses of neuroimaging for cognitively impaired patients (2008) (157)
- Mapping Histology to Metabolism: Coregistration of Stained Whole-Brain Sections to Premortem PET in Alzheimer's Disease (1997) (141)
- Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. (2002) (140)
- Apolipoprotein E controls the risk and age at onset of Parkinson disease (2004) (140)
- Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. (2001) (138)
- Predictors of cognitive change in middle-aged and older adults with memory loss. (1995) (135)
- A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch (2007) (126)
- Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. (2000) (123)
- Reduction in radiation exposure in cardiovascular computed tomography imaging: results from the PROspective multicenter registry on radiaTion dose Estimates of cardiac CT angIOgraphy iN daily practice in 2017 (PROTECTION VI) (2018) (122)
- What we need to know about age related memory loss (2002) (119)
- Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease (2010) (115)
- Complete Genomic Screen in Late-Onset Familial Alzheimer’s Disease (1998) (113)
- Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP. (2017) (111)
- Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. (2002) (111)
- 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease. (2003) (110)
- Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22. (2003) (103)
- The Impact of Symptom Severity on the Cost of Alzheimer's Disease (2002) (103)
- PET imaging of neuropathology in tauopathies: progressive supranuclear palsy. (2013) (99)
- Estrogen use and brain metabolic change in postmenopausal women (2004) (99)
- Positron emission tomography imaging of dementia (2000) (94)
- Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset. (1989) (94)
- An economic evaluation of donepezil in the treatment of Alzheimer's disease. (1998) (93)
- Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease (1997) (92)
- Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults. (2009) (90)
- An α-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease (1999) (88)
- No Genetic Effect of α1-Antichymotrypsin in Alzheimer Disease (1996) (88)
- Clinical Value of Neuroimaging in the Diagnosis of Dementia. Sensitivity and Specificity of Regional Cerebral Metabolic and Other Parameters for Early Identification of Alzheimer's Disease. (1999) (88)
- Mood Symptoms and Cognitive Performance in Women Estrogen Users and Nonusers and Men (2002) (86)
- Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism (2010) (85)
- An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia. (2003) (83)
- Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele. (1999) (81)
- Investigation of partial volume correction methods for brain FDG PET studies (1996) (80)
- Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians (2013) (77)
- Modifiable Risk Factors for Alzheimer Disease and Subjective Memory Impairment across Age Groups (2014) (73)
- Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease (2011) (72)
- Family history of Alzheimer's disease and hippocampal structure in healthy people. (2010) (71)
- Protein binding in patients with late-life depression. (2011) (71)
- Apolipoprotein E genotype and noncognitive symptoms in Alzheimer’s disease (1999) (69)
- Impact of Physical Illness on Quality of Life and Antidepressant Response in Geriatric Major Depression (1996) (69)
- Prediction of cognitive decline by positron emission tomography of brain amyloid and tau. (2012) (69)
- Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates (2010) (68)
- Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. (2009) (67)
- Pharmacokinetic rationale for the rivastigmine patch (2007) (66)
- Pomegranate Juice Augments Memory and fMRI Activity in Middle-Aged and Older Adults with Mild Memory Complaints (2013) (64)
- Outbreak of illness in a school chorus. Toxic poisoning or mass hysteria? (1983) (63)
- Positron Emission Tomography in Evaluation of Dementia (2001) (62)
- Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. (2003) (62)
- Recognition and treatment of depression in the elderly. (1991) (61)
- Mass hysteria among schoolchildren. Early loss as a predisposing factor. (1982) (61)
- APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease (2013) (61)
- Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. (2003) (60)
- Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome. (2011) (60)
- Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease. (2001) (60)
- Health-Promoting Strategies for the Aging Brain. (2019) (60)
- Long‐term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease (2003) (59)
- Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease (2007) (58)
- Early Detection of Alzheimer's Disease by Combining Apolipoprotein E and Neuroimaging a (1996) (58)
- The pathogenesis of Alzheimer's disease. (1998) (57)
- The merits of FDDNP-PET imaging in Alzheimer's disease. (2011) (56)
- An Alzheimer’s Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults (2016) (56)
- PET of Brain Prion Protein Amyloid in Gerstmann–Sträussler–Scheinker Disease (2010) (55)
- Sulcal variability in the Alzheimer's brain (1998) (53)
- Positron emission tomography scans obtained for the evaluation of cognitive dysfunction. (2008) (53)
- Brain health consequences of digital technology use (2020) (52)
- Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults (2018) (51)
- Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints. (2016) (51)
- Visualizing pathology deposits in the living brain of patients with Alzheimer's disease. (2006) (50)
- Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia. (2003) (50)
- Mass hysteria among student performers: social relationship as a symptom predictor. (1991) (49)
- Postmortem Autopsy‐Confirmation of Antemortem [F‐18]FDDNP‐PET Scans in a Football Player With Chronic Traumatic Encephalopathy (2018) (49)
- Efficacy of Rivastigmine in Alzheimer’s Disease Patients with Rapid Disease Progression: Results of a Meta-Analysis (2005) (49)
- Movement Correction Method for Human Brain PET Images: Application to Quantitative Analysis of Dynamic 18F-FDDNP Scans (2010) (47)
- Diagnostic Issues in Dementia: Neuroimaging as a Surrogate Marker of Disease (2006) (46)
- In vivo brain imaging of tangle burden in humans (2002) (46)
- Age-Associated Memory Loss: Initial Neuropsychological and Cerebral Metabolic Findings of a Longitudinal Study (1994) (46)
- Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study. (2008) (45)
- Recognizing and treating anxiety in the elderly. (1997) (45)
- Entorhinal cortex structure and functional MRI response during an associative verbal memory task (2009) (44)
- Hippocampal Atrophy in Persons With Age-Associated Memory Impairment: Volumetry Within a Common Space (2002) (43)
- Family History and APOE-4 Genetic Risk in Alzheimer’s Disease (2012) (43)
- Imaging beta-amyloid fibrils in Alzheimer's disease: a critical analysis through simulation of amyloid fibril polymerization. (2005) (42)
- Meet Your iBrain (2008) (42)
- [F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: Effects of aging, in vivo blockade, and anti-Aβ antibody treatment (2011) (42)
- Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment. (2002) (42)
- Dementia Diagnostic Guidelines: Methodologies, Results, and Implementation Costs (2000) (42)
- No genetic association between the LRP receptor and sporadic or late-onset familial Alzheimer disease (1998) (40)
- Oral tetrahydroaminoacridine in the treatment of senile dementia, Alzheimer's type. (1987) (40)
- Estrogen use and brain metabolic change in older adults. A preliminary report (2001) (40)
- The management of depression and anxiety in the elderly. (1995) (40)
- Therapeutic Potential of TNF-α Inhibition for Alzheimer’s Disease Prevention (2020) (40)
- Further evidence linking late-onset Alzheimer disease with chromosome 12. (1999) (39)
- Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment (2008) (38)
- Influence of Alzheimer disease family history and genetic risk on cognitive performance in healthy middle-aged and older people. (2012) (38)
- Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K) (1999) (38)
- Galantamine in the Treatment of Cognitive Decline in Patients with Vascular Dementia or Alzheimer’s Disease with Cerebrovascular Disease (2003) (38)
- An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. (1999) (38)
- The memory fitness program: cognitive effects of a healthy aging intervention. (2012) (38)
- Treatment of Alzheimer's disease: current approaches and promising developments. (1998) (36)
- Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region (2008) (35)
- Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation (2011) (35)
- Clinical Response Predictors in a Double-Blind, Placebo-Controlled Trial of Fluoxetine for Geriatric Major Depression (1995) (35)
- To help aging populations, classify organismal senescence (2019) (35)
- Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis (2021) (34)
- Multimodal Imaging of Alzheimer Pathophysiology in the Brain's Default Mode Network (2011) (34)
- Thyroid Disease in Patients With Dementia of the Alzheimer Type (1985) (34)
- Vascular health risks and fMRI activation during a memory task in older adults (2010) (33)
- No association or linkage between an intronic polymorphism of presenilin‐1 and sporadic or late‐onset familial Alzheimer disease (1997) (33)
- Memory self‐appraisal and depressive symptoms in people at genetic risk for Alzheimer's disease (2001) (33)
- Randomized placebo-controlled study of the memory effects of pomegranate juice in middle-aged and older adults. (2019) (32)
- A sudden outbreak of illness suggestive of mass hysteria in schoolchildren. (1994) (32)
- Clinical, neuroimaging, and environmental risk differences in monozygotic female twins appearing discordant for dementia of the Alzheimer type. (1993) (31)
- Altered memory‐related functional connectivity of the anterior and posterior hippocampus in older adults at increased genetic risk for Alzheimer's disease (2016) (31)
- Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging. (2013) (31)
- Object naming and semantic fluency among individuals with genetic risk for Alzheimer's disease (2005) (31)
- Dissecting molecular mechanisms in the living brain of dementia patients. (2009) (30)
- Thickness in Entorhinal and Subicular Cortex Predicts Episodic Memory Decline in Mild Cognitive Impairment (2011) (30)
- Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease. (2006) (29)
- The α-synuclein gene is not a major risk factor in familial Parkinson disease (1999) (29)
- MMSE Items Predict Cognitive Decline in Persons with Genetic Risk for Alzheimer's Disease (2003) (29)
- Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease (2010) (29)
- No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians (1996) (29)
- Diagnosis and treatment of dementia in the aged. (1981) (29)
- Simultaneous Aerobic Exercise and Memory Training Program in Older Adults with Subjective Memory Impairments (2018) (29)
- The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease. (1995) (29)
- Pseudocyesis: An Overview * (1986) (28)
- Differential diagnoses and assessment of depression in elderly patients. (2009) (28)
- Neuroimaging as a Diagnostic Tool in Dementia with Lewy Bodies (2003) (27)
- Training in geriatric psychiatry: will the supply meet the demand? (1988) (27)
- FDDNP binding using MR derived cortical surface maps (2010) (26)
- Differential diagnosis and early detection of dementia. (1998) (26)
- Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease. (1996) (25)
- Reliability of drawing regions of interest for positron emission tomographic data (1992) (25)
- Exploring the association of glyceraldehyde-3-phosphate dehydrogenase gene and Alzheimer disease (2006) (25)
- HLA-A2 as a possible marker for early-onset Alzheimer disease in men (1986) (25)
- Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia (2012) (23)
- Healthy behavior and memory self-reports in young, middle-aged, and older adults (2013) (23)
- Subjective memory loss in age-associated memory impairment: Family history and neuropsychological correlates (1996) (23)
- Automated Movement Correction for Dynamic PET/CT Images: Evaluation with Phantom and Patient Data (2014) (23)
- Tacrine for treating Alzheimer's disease. (1992) (22)
- Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease. (2002) (22)
- Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant (2017) (22)
- Psychopharmacological treatment of elderly demented patients. (1988) (22)
- Psychiatric consultation for the medically ill elderly in the general hospital: need for a collaborative model of care. (1988) (22)
- Prevention in psychiatry: effects of healthy lifestyle on cognition. (2011) (21)
- Neural correlates of apathy in late‐life depression: a pilot [18F]FDDNP positron emission tomography study (2017) (21)
- Subregional Hippocampal Thickness Abnormalities in Older Adults with a History of Heavy Cannabis Use (2018) (21)
- Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease. (2005) (21)
- Trazodone and cocaine abuse. (1985) (21)
- No association between the HLA-A2 allele and Alzheimer disease (1999) (20)
- Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety. (1997) (20)
- Seeing is believing: neuroimaging adds to our understanding of cerebral pathology (2006) (20)
- Summer Research Institute (2001) (19)
- Cerebral metabolic patterns in untreated postmenopausal women with major depressive disorder (2008) (19)
- Treatment of geriatric depression (1998) (19)
- Surface Feature-Guided Mapping of Cerebral Metabolic Changes in Cognitively Normal and Mildly Impaired Elderly (2009) (19)
- No genetic effect of alpha1-antichymotrypsin in Alzheimer disease. (1996) (18)
- The influence of age on guilt expression in major depression (1986) (18)
- Revised Ischemic Score for diagnosing multi-infarct dementia. (1985) (18)
- Differential FDDNP PET patterns in nondemented middle-aged and older adults. (2009) (17)
- The alpha-synuclein gene is not a major risk factor in familial Parkinson disease. (1999) (17)
- Neuroimaging for diagnosis of dementia. (1998) (17)
- Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson’s disease (2003) (17)
- Characteristics of fluoxetine versus placebo responders in a randomized trial of geriatric depression. (1997) (16)
- FDDNP-PET Tau Brain Protein Binding Patterns in Military Personnel with Suspected Chronic Traumatic Encephalopathy1. (2018) (16)
- SITE VARIABILITY IN A MULTISITE GERIATRIC DEPRESSION TRIAL (1996) (16)
- Brain-imaging surrogate markers for detection and prevention of age-related memory loss (2002) (15)
- Verbal fluency as a screening tool for mild cognitive impairment (2019) (15)
- Physical Activity and Hippocampal Sub-Region Structure in Older Adults with Memory Complaints (2019) (15)
- A cross-species approach to disorders affecting brain and behaviour (2018) (15)
- Mnemonics Usage and Cognitive Decline in Age-Associated Memory Impairment (1997) (15)
- Neuropsychological tests for predicting cognitive decline in older adults. (2015) (15)
- Early diagnosis of Alzheimer's disease: update on combining genetic and brain-imaging measures (2000) (14)
- Treating dementia and agitation. (2014) (14)
- Progressive Focal Gray Matter Volume Loss in a Former High School Football Player: A Possible Magnetic Resonance Imaging Volumetric Signature for Chronic Traumatic Encephalopathy. (2016) (14)
- Side effects and time course of response in a placebo-controlled trial of fluoxetine for the treatment of geriatric depression. (2000) (14)
- Variable association of HLA-A2 in men with early-onset Alzheimer disease (1991) (14)
- The Q7R Saitohin gene polymorphism is not associated with Alzheimer disease (2003) (13)
- Data omitted from psychiatric consultation notes. (1988) (13)
- The C677T variant in MTHFR modulates associations between brain integrity, mood, and cognitive functioning in old age. (2017) (13)
- Sleep quality, neurocognitive performance, and memory self-appraisal in middle-aged and older adults with memory complaints (2020) (13)
- Hot Topics in Research: Preventive Neuroradiology in Brain Aging and Cognitive Decline (2015) (13)
- Complete genomic screen in Parkinson Disease (2001) (12)
- Biologic markers, genetics, and Alzheimer's disease. (1988) (12)
- The influence of newspaper reports on outbreaks of mass hysteria (2005) (12)
- No Association between α1‐Antichymotrypsin and Familial Alzheimer's Diseases a (1996) (11)
- Estrogen effects on the brain. (1998) (11)
- D2 dopamine receptor A1 allele in Alzheimer disease and aging. (1997) (11)
- Detection and Prevention of Cognitive Decline. (2016) (11)
- Prediction of cognitive decline based on hemispheric cortical surface maps of FDDNP PET (2012) (11)
- Coexistence of Alzheimer's Disease and Diabetes Mellitus (1992) (11)
- Assessment of dementia risk in aging adults using both FDG‐PET and FDDNP‐PET imaging (2012) (10)
- Central Nervous System IgG Synthesis Rates in Alzheimer Disease: Possible Differences in Early‐Onset and Late‐Onset Subgroups (1994) (10)
- A Genomic Search for Alzheimer's Disease Genes (2002) (10)
- Therapeutics for cognitive aging (2010) (10)
- KIAA1462, A Coronary Artery Disease Associated Gene, Is a Candidate Gene for Late Onset Alzheimer Disease in APOE Carriers (2013) (10)
- Mood, cognition and in vivo protein imaging: the emerging nexus in clinical neuroscience (2008) (10)
- Memory, Aging, and Dementia (1991) (9)
- The role of neuroimaging in the diagnosis of vascular dementia (2002) (9)
- Behavioral risk factors for self-reported depression across the lifespan (2018) (9)
- Borderline Personality Disorder in the Elderly: A Case Study (1986) (9)
- Memory Self-Appraisal and Cerebral Glucose Metabolism in Age-Associated Memory Impairment. (1995) (9)
- Psychological well-being and regional brain amyloid and tau in mild cognitive impairment. (2014) (9)
- Thalamo-Basal Ganglia Connectivity in Postmenopausal Women Receiving Estrogen Therapy (2009) (9)
- Clinical Characterization of Alzheimer's Disease: Reliability of 'Age at Onset' and a New Descriptor, 'Age at Shift' (1988) (8)
- 233 Complete genomic screen in late-onset familial Alzheimer disease (1996) (8)
- Inside Doctoring: Stages and Outcomes in the Professional Development of Physicians (1986) (8)
- Erratum: Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease (Human Molecular Genetics (2003) vol. 12 (3259-3267)) (2004) (8)
- Treatment of Late-Life Depression: Progress and Challenge (1995) (8)
- Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding (2018) (8)
- In vitro and in vivo binding characteristics of two biological probes for plaques and tangles in alzheimer's disease (2001) (8)
- Comparison of simplified methods for quantitative analysis of [18F]FDDNP PET data (2007) (8)
- Pomegranate Metabolites Impact Tryptophan Metabolism in Humans and Mice (2020) (8)
- Mutation analysis of presenillin 1 gene in Alzheimer's disease. (1996) (7)
- Tricyclic antidepressants for medically ill geriatric patients. (1989) (7)
- Results and insights from a phase I clinical trial of Lomecel‐B for Alzheimer's disease (2022) (7)
- P2-206 In vivo brain imaging of tau aggregation in frontal temporal dementia using [F-18]FDDNP positron emission tomography (2004) (7)
- Current and Future Treatments for Alzheimer Disease. (2015) (7)
- A-12Screening for Mild Cognitive Impairment (MCI) with the Mini-Mental Status Exam (MMSE) and Rey-Osterrieth Complex Figure Test (ROCF) (2014) (7)
- In Vivo Brain Plaque and Tangle Burden Mediates the Association Between Diastolic Blood Pressure and Cognitive Functioning in Nondemented Adults. (2018) (7)
- Movement correction of [18F]FDDNP PET studies for brain amyloid imaging (2007) (7)
- Nutrition and Brain Health (2013) (7)
- Geriatric Psychiatry Fellowship Recruitment: Crisis or Opportunity? (1993) (6)
- Physical symptoms in patients with primary degenerative dementia. (1986) (6)
- Prompt identification of Alzheimer's disease with brain PET imaging of a woman with multiple previous diagnoses of other neuropsychiatric conditions. (2002) (6)
- Meeting the challenges of vascular dementia. Introduction. (2001) (6)
- What Does Imaging Add to the Management of Alzheimer's Disease? (2004) (6)
- Positron emission tomography scanning for the early diagnosis of dementia. (1999) (6)
- Positron Emission Tomography of Brain (cid:2) -Amyloid and Tau Levels in Adults With Down Syndrome (2011) (6)
- The Value of In Vitro Binding as Predictor of In Vivo Results: A Case for [18F]FDDNP PET (2018) (6)
- Vascular dementia: galantamine (Reminyl®) as an emerging therapeutic option (2002) (5)
- P2-274 FDDNP-PET binding differentiates MCI from dementia and increases with clinical progression (2006) (5)
- Investigations into geriatric psychiatry challenges: AAGP Senior Investigator Award 2000. (2000) (5)
- Fine-mapping of the chromosome 12 Alzheimer disease locus using family-based association tests of microsatellite markers (2000) (5)
- Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders (2019) (5)
- [18F]FDDNP PET binding predicts change in executive function in a pilot clinical trial of geriatric depression (2020) (5)
- Comparative evaluation of Logan and relative-equilibrium graphical methods for parametric imaging of dynamic [18F]FDDNP PET determinations (2012) (5)
- Psychopharmacology of the aged. (1987) (5)
- Managing the Burden of Dementia Related Delusions and Hallucinations. (2020) (5)
- Beyond Standard Anti-Dementia Therapies: Diet, Exercise, Socialization, and Supplements (2008) (5)
- Diagnostic accuracy of FDG-PET in evaluation of dementia: International multicenter pooled brain scan and autopsy data (2000) (5)
- STRUCTURAL AND FUNCTIONAL BRAIN IMAGING OF ALZHEIMER DISEASE (2002) (5)
- FDDNP-PET Scanning of Cerebral Amyloid and Tau Deposits in MCI (2006) (4)
- O3-03-06 Plaque and tangle brain imaging using [F-18]FDDNP-PET differentiates Alzheimer's disease, mild cognitive impairment, and older controls (2004) (4)
- The C677T variant in MTHFR modulates associations between blood-based and cerebrospinal fluid biomarkers of neurodegeneration (2016) (4)
- Age at onset versus age at examination of Alzheimer-type dementia. (1986) (4)
- CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology (2001) (4)
- Mood state and cerebral metabolism in persons with age-associated memory impairment (1997) (4)
- Brain pathology and neuronal losses in the living brain of Alzheimer's patients (2006) (4)
- Research Proposals: A Guide to Success (1991) (4)
- No association between alpha 1-antichymotrypsin and familial Alzheimer's disease. (1996) (3)
- In vivo [F-18]FDDNP microPET imaging of brain B-amyloid in a transgenic rat model of Alzheimer’s disease (2005) (3)
- Pharmacotherapy and other treatments for elderly patients with depression. (2010) (3)
- [F-18]FDDNP PET imaging of prion pathology in Gerstmann-Strausller-Scheinker disease (2007) (3)
- MEMORY AND BRAIN AMYLOID AND TAU EFFECTS OF CURCUMIN IN NON-DEMENTED ADULTS: A DOUBLE-BLIND, PLACEBO-CONTROLLED 18-MONTH TRIAL (2017) (3)
- A bootstrap method for identifying image regions affected by intra-scan body movement during a PET/CT scan (2011) (3)
- Vascular risk and FDDNP-PET influence cognitive performance. (2013) (3)
- HLA Antigens in Depressed, Demented, and Nondemented Elderly (1989) (3)
- Genomic screen of 739 sibpairs with late onset Alzheimer disease (2000) (3)
- Automated VOI Analysis in FDDNP PET Using Structural Warping: Validation through Classification of Alzheimer's Disease Patients (2012) (3)
- Alzheimer's disease: Current progress, future promise (1998) (3)
- Academic highlights: emerging therapeutic strategies in Alzheimer's disease. (2004) (2)
- Hormone Treatments for Behavioral and Psychological Symptoms of Dementia (2000) (2)
- Psychiatric problems affecting dental care of the elderly. (1984) (2)
- Hemispheric cortical surface map for assessing the rate of changes of regional cortical FDDNP distribution volume versus MMSE score (2007) (2)
- Influence of APOE genotype and pet brain imaging on preclinical prediction of Alzheimer disease (2000) (2)
- O2-02-05 FDDNP-PET binding values from cortical hemispheric surface maps correlate with MMSE scores (2007) (2)
- Microstructural Imaging of Neurodegenerative Changes (2009) (2)
- The impact of age and Alzheimer's disease risk factors on memory performance over time (2013) (2)
- Lifestyle Behaviors Promoting Mental Health in Older Adults (2013) (2)
- Depression in the aged. A commentary. (1982) (2)
- Anxiety and verbal memory performance in APOE-4 carriers and noncarriers aged 50 years and above. (2012) (2)
- Neuroimaging, neuropsychological, and genetic assessments for early detection of Alzheimer disease (1996) (2)
- The increasing power of placebos in trials of antidepressants. (2002) (2)
- Psychiatry: indications for monitoring psychotherapeutic drug concentrations. (1985) (2)
- Living Better Longer Through Technology (1999) (2)
- Hannah's Heirs: The Quest for the Genetic Origins of Alzheimer's Disease (1994) (2)
- Corrigendum to “Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation” [Neurosci. Lett. 487 (2011) 287–292] (2011) (2)
- The 1998 Workshop on Neuroimaging Research in Alzheimer's Disease: Observation and issues (2000) (2)
- Healthy behavior and memory self-reports in young, middle-aged, and older adults (2013) (2)
- That Boorish, Insensitive, Loudmouthed, Crass Physician in the Elevator (1985) (2)
- Depression and Anxiety Symptoms Are Associated with Cerebral FDDNP-PET Binding in Middle-Aged and Older Non-Demented Adults (2009) (2)
- Response to Letter from Shin and Lee, entitled "FDDNP PET patterns in nondemented populations" (2010) (1)
- Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosis. (2022) (1)
- The Effect of Memory Training on Memory Control Beliefs in Older Adults with Subjective Memory Complaints (2020) (1)
- Effects of estrogen on cognition and mood functioning in older adults (2000) (1)
- Vascular and genetic risk factors influence hippocampal thickness (2015) (1)
- THE SUMMER RESEARCH INSTITUTE IN GERIATRIC PSYCHIATRY: THREE YEARS OF FOLLOW-UP DATA (1999) (1)
- Language performance in postmenopausal women with and without hormone therapy and men. (2012) (1)
- The Neurobiology of Down Syndrome (1988) (1)
- Clinical Evaluation of Dementia and When to Perform PET (2009) (1)
- The Role of Positron Emission Tomography in the Diagnosis of Alzheimer's Disease (2004) (1)
- The Alzheimer's disease research imperative. (1989) (1)
- Geriatric Psychiatry: Key Research Topics for Clinicians (1997) (1)
- Usefulness of Positron Emission Tomography in Evaluating Dementia—Reply (2002) (1)
- Longitudinal study of changes in FDDNP-PET and neuropsychological scores (2011) (1)
- Dealing with writer's block in an older man: depression, Parkinson's disease, or both? (1991) (1)
- Paranoid disorders in the aged. Diagnostic and therapeutic issues. (1982) (1)
- Is Aging a Disease? Subjective Cognitive Impairment and Physiologic Factors (2016) (1)
- The year book of geriatrics and gerontology (1994) (1)
- Health manpower shortage in geriatric psychiatry. (1983) (1)
- O3-06-06 [18F]FDDNP-PET imaging in persons at-risk for familial AD (2006) (1)
- P2-374 MR-guided 3D PET mapping of longitudinal changes in regional cerebral metabolism of normal subjects (2006) (1)
- New developments in the treatment of Alzheimer's disease the planning teleconference series (2009) (1)
- Munchausen's Syndrome in an 85‐Year‐Old Man (1985) (1)
- Updates in the Management of Mild Cognitive Impairment and Alzheimer Disease. (2022) (1)
- An attentional task in subjects at genetic risk for Alzheimer's disease (2001) (1)
- Simplified quantification of FDDNP PET studies (2011) (1)
- The usefulness of Canadian Army Selection Tests in a culturally restricted population. (1969) (1)
- D 2 Dopamine Receptor A 1 Allele in Alzheimer Disease and Aging (1)
- Peer-Led Memory Training Programs to Support Brain Fitness (2011) (1)
- The inherent challenges of classifying senescence—Response (2020) (1)
- Effect of Pomegranate Juice Consumption on Plasma Indole Propionic Acid, a Bacterial-Derived Tryptophan Metabolite (P20-003-19). (2019) (1)
- Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel (2022) (1)
- Response to Letter From Shin and Lee, Entitled 2-(1-{6-[(2-[Fluorine- 18]Fluoroethyl)(Methyl) Amino]-2-Naphthyl} Ethylidene)Malononitrile Positron Emission Tomography Patterns in Nondemented. Populations (2010) (1)
- Management of Age-Related Cognitive Decline (2019) (1)
- Concurrent Munchausen's and 'VIP' syndromes. (1992) (1)
- Memory Training for Older Adults (2010) (1)
- Early diagnosis of Alzheimer's disease. (1997) (1)
- Mass Media and Mass Hysteria (1986) (1)
- Evaluation of two graphical approaches for regional analysis and parametric mapping of dynamic [18F]FDDNP PET studies (2009) (1)
- The Search for Additional Alzheimer’s Disease Genes (1996) (1)
- Psychiatry: mass hysteria. (1985) (1)
- P1-292: Glucose metabolic, amyloid, and tau brain imaging in down syndrome and dementia (2008) (1)
- Early Loss as a Predisposing Factor (2017) (0)
- P4-138 Genomic convergence on chromosome 12 in Alzheimer's disease (2004) (0)
- Weighted and unweighted genetic risk scores are associated with longitudinal cortical thinning of hippocampal complex subregions (2015) (0)
- Drs. Small and Beck Reply (1989) (0)
- IC-P3-218: Long-term effects of donepezil versus placebo on regional brain metabolism in minimally impaired subjects (2008) (0)
- Clinical and quantitative fluorodeoxyglucose positron emission tomography in presymptomatic and symptomatic persons inheriting familial Alzheimer's disease mutations (2010) (0)
- Teamwork in Alzheimer's disease: the interdisciplinary approach to treatment. (2000) (0)
- P2-300 In vivo quantification of neuronal loss and neuropathological deposition in Alzheimer’s disease with PET (2006) (0)
- Neural correlates of apathy in late-life depression: a pilot [18F]FDDNP PET study: Apathy in late-life depression (2017) (0)
- Letters to the editor (1993) (0)
- Weighted and unweighted genetic risk scores are associated with longitudinal cortical thinning of hippocampal complex subregions (2015) (0)
- In vivo imaging of beta-amyloid load in transgenic rodents with [F-18]FDDNP microPET (2005) (0)
- The 12-Month Effects of Galantamine in Probable Vascular Dementia and Mixed Dementia (2003) (0)
- Modifiable Risk Factors and Reports of Depression in Young, Middle-aged, and Older Adults (2013) (0)
- Analysis of chromosome 12 candidate genes in late-onset Alzheimer disease (2000) (0)
- GENDER DIFFERENCES IN MEMORY-RELATED FUNCTIONAL CONNECTIVITY IN AGING AND GENETIC RISK FOR AD (2014) (0)
- Effects of a Fourteen-Day Healthy Longevity Lifestyle Program on Cognition and Brain Function (2008) (0)
- International Concussion Consensus 2015 (2015) (0)
- Family History and APOE-4 Genetic Risk in Alzheimer’s Disease (2012) (0)
- The TabCAT Brain Health Assessment: A Highly Efficient and Sensitive Approach to Detecting Very Mild Cognitive Impairment (P5.197) (2016) (0)
- Positron Emission Tomography in Dementia (1993) (0)
- Altered memory-related functional connectivity of the anterior and posterior hippocampus in older at increased genetic risk (2015) (0)
- Dr. Small Replies (2007) (0)
- Development of an Expert Consensus Approach to Screening, Assessment, and Diagnosis of Patients at Risk for Neurodegenerative Disease (S1.006) (2016) (0)
- P4-080 Genetic studies of Alzheimer disease on chromosome 9P (2004) (0)
- Treatment of depression in the elderly. (1983) (0)
- Geriatric psychopharmacology. (1989) (0)
- The Treatment of Alzheimer's Disease: Comparing Guidelines (2009) (0)
- Modifiable Risk Factors for Neurodegeneration (2014) (0)
- Clinical and Quantitative Fluorodeoxyglucose Positron Emission Tomography in Pre- and Symptomatic Persons Inheriting Familial Alzheimer's Disease Mutations (2010) (0)
- Title Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults Permalink (2018) (0)
- Early Detection and Treatment of Age-Related Cognitive Decline (2020) (0)
- Emission Tomography Scans btained for the Evaluation of Cognitive Dysfunction (0)
- MYOCARDIAL BLOOD FLOW UTILITY IN 195 CONSECUTIVE CASES (2021) (0)
- P1-334 Does rivastigmine response vary according to rate of change? (2004) (0)
- Geriatric neuropsychologyEffects of estrogen on cognition and mood functioning in older adults (2000) (0)
- B-05Role of a Computerized Brain Fitness Program in Managing Mood Among Older Adults (2013) (0)
- INTERNET SEARCH TRAINING AND PRACTICE AFFECT BRAIN ACTIVATION PATTERNS IN OLDER ADULTS (2017) (0)
- 73 Pharmacological rationale for cholinesterase inhibition in Alzheimer's disease (2012) (0)
- Title Altered memory-related functional connectivity of the anterior and posterior hippocampus in older adults at increased genetic risk for Alzheimer ' s disease (2015) (0)
- Brain Imaging Surrogate Markers for Detection and Prevention of Cognitive Aging and Alzheimer's Disease (2002) (0)
- Insomnia sometimes improves with such simple remedies as eliminating daytime napping and taking hot milk and tryptophan-0 . 5 to 1 gram-at bedtime (0)
- Title Treating dementia and agitation Permalink (2014) (0)
- Effects of Bioavailable Curcumin on Age-Related Cognitive Symptoms (2018) (0)
- GENDER DIFFERENCES IN MEMORY-RELATED FUNCTIONAL CONNECTIVITY IN AGING AND GENETIC RISK FOR AD (2014) (0)
- IC-P1-057: Glucose metabolic, amyloid, and tau brain imaging in down syndrome and dementia (2008) (0)
- Movement correction method for dynamic PET/CT images: Application to Down syndrome 18F-FDDNP dynamic scans (2011) (0)
- GUEST EDITORIAL for THE AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY CURRENT AND FUTURE TREATMENTS FOR ALZHEIMER’S DISEASE (2015) (0)
- Characterization of Tau Association with Parkinson's Disease (2003) (0)
- P-203 Cognitive and cerebral metabolic effects of celecoxib in people with age-related memory complaints (2007) (0)
- Genes, Brain, and Behavior (1992) (0)
- IC-P2-093: Differential FDDNP-PET patterns identify subgroups of middle-aged and older adults (2008) (0)
- Paired-associative learning in patients at genetic risk for Alzheimer's disease (2000) (0)
- How accurately can FDG-PET scans predict individual rates of cognitive decline? (2006) (0)
- News briefs (1995) (0)
- Evaluation of the use of voxel-value distribution in target regions in longitudinal FDDNP PET studies (2013) (0)
- Relationship of FDDNP-PET (amyloid and tau marker) to bmi, physical activity, and diet in older adults without dementia (2015) (0)
- Physiological Neuroimaging in Ageing and Dementia: Metabolic and Molecular Scanning (2010) (0)
- POST-MENOPAUSAL BREAST ARTERIAL CALCIFICATIONS (BACS) IN WOMEN AS A POSSIBLE BIOMARKER FOR INCREASED RISK OF DEVELOPING DEMENTIA: STUDY RATIONALE, DESIGN, AND METHODOLOGY (2019) (0)
- Automated VOI analysis in 18 F-FDDNP PET using structural warping: Validation through classification of Alzheimer's disease patients (2010) (0)
- IC-P-085 MR-guided 3D PET mapping of longitudinal changes in regional cerebral metabolism of normal subjects (2006) (0)
- Alzheimer's disease: Making progress through a multidisciplinary approach (1998) (0)
- MONEY AND MEDICINE (1977) (0)
- Objective—We sought to examine the risk of mortality associated with nonobstructive coronary artery disease (CAD) and to determine the impact of baseline statin and aspirin use on mortality. Approach and Results—Coronary computed tomographic angiography permits direct visualization of nonobstructive (2015) (0)
- Amyloid Imaging in AD , MCI , DLB , PDD , PD , and FTD using 11 CPIB PET (0)
- Memory Self-appraisal and Pet of Brain Amyloid and Tau in Persons Without Dementia (2010) (0)
- IC-103-02 Cerebral FDDNP-PET binding increases in MCI and aging as neurodegeneration progresses (2006) (0)
- In Vivo Visualization of Amyloid-Like Structures in Humans (2011) (0)
- Parentcare : a commonsense guide for adult children (1988) (0)
- Invited Perspective on "A Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics on Time to Rehospitalization Within One Year of Discharge in Elderly Patients With Schizophrenia". (2019) (0)
- Movement correction improves quantitative analysis of dynamic 18F-FDDNP PET images (2008) (0)
- Handbook for Clinical Memory Assessment of Older Adults.: Book Review Editor (1988) (0)
- On early Alzheimer's disease presenting as pseudoseizures. (1994) (0)
- Influence of age, grey matter, and memory performance on fMRI activation in older adults (2005) (0)
- LettersThe author replies (1982) (0)
- Method for positron emission tomography (pet) imaging analysis for classifying and diagnosing of neurological diseases (2017) (0)
- IM-08 Imaging and genes in the aging brain (2007) (0)
- DRS. Small and Siegel Reply (1987) (0)
- Prediction of cognitive change based on hemispheric cortical surface maps of FDDNP (2009) (0)
- Research Update: Healthy Aging and Prevention of Late-Life Mood and Cognitive Disorders (Sponsored by the AAGP Research Committee; Chaired by Helen Lavretsky, M.D.) (2015) (0)
- Curcumin May Improve Age-Associated Memory Issues (2018) (0)
- Response to Letter About Memory and Brain Effects of Curcumin. (2018) (0)
- DSM-III diagnosis of dementia. (1983) (0)
- Geriatric psychiatry. A specialty in its youth. (1982) (0)
- Alzheimer’s Disease and Inflammation (2014) (0)
- P2-243 Slower cognitive decline in patients receiving rivastigmine for up to 5 years (2004) (0)
- A novel data-driven approach to order subjects with neurodegenerative disease based on PET imaging data alone (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gary W. Small?
Gary W. Small is affiliated with the following schools:
